Table 1. Rare nsSNVs identified in 36/44 HCM patients. A comment inferred from review of literature, in silico predictions and evolution conservation analysis, is given for each DNA change in the last column. Based on those considerations and on the type of variant, comments with a gray background highlight DNA changes predicted to be possibly pathogenetic. Comments in bold stand for DNA variants that have been previously reported as phenotype modifying factors.
Case: Bottillo Patient 17, Female, 50 yrs at diagnosis
CasePresentingHPOs: copy from group
CasePresentingHPOsFreeText: NYHA functional class 2, maximal wall thickness=14mm, left ventricular mass (at CMRI)=91(mg/m2), LVEF=52%, maximal oxygen uptake=78%, diastolic dysfunction grade=3, QT interval corrected for heart rate=0.4ms, thoracic pains, met ECG hypertrophy criteria, left bundle branch block, heart failure, mild intramyocardial CMRI
CaseNOTHPOs:
CaseNOTHPOSFreeText: family history of HCM or SCD
CasePreviousTesting: copy from group
CaseGenotypingMethod: copy from group
Variant: c.4485-6T>C
ClinVarID: or CAID: CA2573331909
gnomAD: This proband has an intronic missense variant that is not present in gnomAD. Pt also has variants in TNNT2 (p.R84S), RBM20 (p.D20G), CAV3 (p.T78M), and MYPN (p.A135A) which are either not present in or have conflicting interpretations of pathogenicity in ClinVar. This proband is scored reduced points.
AddCaseInfo:
PreviouslyPublished: no
VariantEvidence: Predicted branch-point splice site broken.